Genetic alterations in cervical carcinomas: Frequent low-level amplifications of oncogenes are associated with human papillomavirus infection

International Journal of Cancer

Volumn 101, Issue 5, 2002, Pages 427-433

  Zhang, Anju ^a   Månér, Susanne ^a   Betz, Regina ^a   Ångström, Tord ^b   Stendahl, Ulf ^c   Bergman, Frank ^b   Zetterberg, Anders ^a   Wallin, Keng Ling ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

20q13.2; C MYC; CCND1; Cervical carcinoma; ERBB2; Gene amplification; Human papillomavirus; PIK3CA; TERT

Indexed keywords

DNA;

ARTICLE; CANCER GROWTH; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE LOCUS; GENE NUMBER; GENETIC ANALYSIS; INTERPHASE; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR; VIRUS INFECTION; WART VIRUS;

BASE SEQUENCE; CHROMOSOME MAPPING; DNA PRIMERS; DNA, VIRAL; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; ONCOGENES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0037057508     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10627     Document Type: Article

References (48)

1. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
2. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product
3. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
4. The molecular genetics of cervical carcinoma
5. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papillomavirus tumor status
6. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
7. Advanced stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q
8. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma
9. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix
10. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genetic hybridization
11. Human papillomavirus status and chromosomal imbalances in primary cervical carcinomas and tumor cell lines
12. Molecular themes in oncogenesis
13. Papillo-mavirus sequences integrate near cellular oncogenes in some cervical carcinomas
14. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyo-typing
15. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression
16. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumors
17. Prognostic significance of the overexpression of c-erbB2 protein in adenocarcinoma of the uterine cervix
18. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of epidermal growth factor receptor is associated with poor prognosis
19. Oncogenes
20. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
21. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
22. The role of phosphoinositide 3-kinase lipid products in cell function
23. Molecular blueprint for targeting cancer?
24. PIK3CA is implicated as an oncogene in ovarian cancer
25. Simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains
26. PIK3CA as an oncogene in cervical cancer
27. Expression analysis of genes at 3q26-27 involved in frequent amplification in squamous cell lung carcinoma
28. Specific association of human telomerase activity with immortal cells and cancer
29. hTEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
30. Telomerase activation in cervical cancer
31. Complex regulation of telomerase activity
32. Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas
33. Direct activation of TERT transcription by c-myc
34. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells
35. Dominant genetic alterations in immortalization: Role for 20 gain
36. Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines
37. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q 24, and 20q13 in human ovarian carcinomas
38. Patterns of chromosomal alterations in metastasizing and non-metastasizing primary head and neck carcinomas
39. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines
40. Positional cloning of ZNF 217 and NABCI: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
41. Frequent amplification of c-erbB2 (Her2/Neu) oncogene in cervical carcinoma as detected by non-fluorescence in situ hybridization technique on paraffin sections
42. Abnormal expression of epidermal growth factor receptor and cerbB2 in squamous cell carcinoma of the cervix: Correlation with human papillomavirus and prognosis
43. 1 cyclin and HPV in the uterine cervix
44. Association between cyclin D1 (CCNDI) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma
45. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix
46. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
47. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes
48. Human papillomavirus type 16 E6 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype